• EO is under regulatory pressure from FDA and EPA
  • Recent litigation has increased risk profile of EO sterilization
  • Slow turnaround times
  • Expensive emissions scrubbing costs
  • EO processing costs are increasing dramatically due to regulation:
    • Emission standards require costly facility upgrades
    • Closure of contractor EO processing facilities


  • Shorter turnaround times – (measured in hours not days)
  • Environmentally friendly solution – recipient of EPA Green Chemistry Award
  • FDA Challenge Grant I recipient
  • Cost effective – operating costs less expensive than EO
  • Broadly compatible with biomaterials

Success Stories

FDA Story

NovaSterilis Provides

  • Multiple regulatory clearances received

Explore Why NovaSterilis

Environmentally Friendly Alternative to EO

Broader Compatibility Including Biologics

Interested in one of our market segments?

Schedule a consultation now.